Compugen (Israel)
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Compugen (Israel), Israel, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
52%
Total
Publications
162
Total Open
Publications
85
Total
Citations
13K
Open Access
Percentage
52%
Total
Publications
162
Total Open
Publications
85
Total
Citations
13K
Breakdown
Publisher Open
15%
Both
20%
Other Platform Open
17%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 33%
19
Hybrid 32%
18
No Guarantees 35%
20
Other Platform Open
Domain 67%
41
Preprint 20%
12
Institution 18%
11
Public 18%
11
Other Internet 15%
9
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 41 |
Europe PMC | Domain | 35 |
Figshare | Public | 12 |
DOI | Other Internet | 9 |
arXiv | Preprint | 6 |
Semantic Scholar | Public | 5 |
University of Bristol - Bristol Research | Institution | 4 |
University College London - UCL Discovery | Institution | 4 |
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna | Institution | 4 |
Zenodo | Public | 3 |